Anti-Atherogenic Effects of a Mixture of Ascorbic Acid, Lysine, Proline, Arginine, Cysteine, and Green Tea Phenolics in Human Aortic Smooth Muscle Cells
Authors:
- M Waheed RoomiMRM Waheed Roomi
- T KalinovskyTKT Kalinovsky
- Aleksandra NiedzwieckiANAleksandra Niedzwiecki
- Matthias RathMRMatthias Rath
- 1 March 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 49 (3) , 140-145
Abstract
Certain drastic behavioral modifications by arterial wall smooth muscle cells (SMC) have been considered key steps in the formation of atherosclerotic lesions: massive migration of SMC from the media to the intima layer of the vessel, dedifferentiation of SMC to proliferating phenotype, and increased secretion of inflammatory cytokines as a response to inflammatory stimuli. We investigated the anti-atherogenic effects of naturally occurring compounds (ascorbic acid, green tea extract, lysine, proline, arginine, and N-acetyl cysteine) using the model of cultured aortic SMC. Cell growth was measured by DNA synthesis, cell invasiveness was measured through Matrigel, matrix metalloproteinase-2 (MMP-2) secretion was measured by zymography, and SMC secretion of monocyte chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6) was measured by immunochemistry. Fetal bovine serum-stimulated SMC growth was inhibited by the nutrient mixture (NM) with 85% inhibition at 100 μg/mL. A corresponding concentration of epigallocatechin gallate (EGCG; 15 μM), the most active tea phenolic, produced a significant effect but one lower than NM. NM inhibited aortic SMC Matrigel invasion in a dose-dependent manner and significantly decreased MMP-2 expression. Stimulation of SMC with tumor necrosis factor-alpha significantly increased production and secretion of such mediators of inflammation as IL-6 and MCP-1; addition of 100 μg/mL NM inhibited secretion of MCP-1 and IL-6 by 65% and 47%, respectively. These data suggest that the NM of ascorbic acid, tea phenolics, and selected amino acids has potential in blocking the development of atherosclerotic lesions by inhibiting atherogenic responses of vascular SMC to pathologic stimuli and warrants in vivo studies.Keywords
This publication has 13 references indexed in Scilit:
- L-Ascorbic Acid Stimulates Expression of Smooth Muscle-Specific Markers in Smooth Muscle Cells both In Vitro and In VivoJournal of Cardiovascular Pharmacology, 2003
- Tea Catechins Prevent the Development of Atherosclerosis in Apoprotein E–Deficient MiceThe Journal of Nutrition, 2001
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient MiceMolecular Cell, 1998
- Ascorbate Affects Proliferation of Guinea-pig Vascular Smooth Muscle Cells by Direct and Extracellular Matrix-mediated EffectsJournal of Molecular and Cellular Cardiology, 1997
- Modulation of collagen synthesis by growth factors: The role of ascorbate-stimulated lipid peroxidationArchives of Biochemistry and Biophysics, 1991
- α-Tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activityArchives of Biochemistry and Biophysics, 1991
- Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and caroteneThe Lancet, 1991
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Regulation of collagen synthesis by ascorbic acid.Proceedings of the National Academy of Sciences, 1981